T Cell Vaccine Targets Malaria Weak Spot | Portland News
Failed to add items
Add to basket failed.
Add to wishlist failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
T Cell Vaccine Targets Malaria Weak Spot | Portland News
-
Narrated by:
-
By:
Scientists have uncovered key malaria parasite fragments that could revolutionize vaccine development by targeting T cells instead of antibodies, offering long-lasting immunity against all strains. This breakthrough, based on global blood sample analysis, reveals a universal immune recognition pattern tied to HLA-E, found in nearly everyone. With malaria still killing hundreds of thousands each year, especially children, this new approach aims to deliver a durable vaccine—potentially lasting decades—without annual boosters. Early tests in primates confirm immune recognition in the liver, a critical battleground for the parasite. This could be the long-awaited tool to finally turn the tide against one of the world’s deadliest diseases.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/9df454e1cc751dbd